BiotechTube
Home/Pipeline/Galapagos Collaboration

Galapagos Collaboration

Inflammatory Bowel Disease

Discovery/Pre-clinicalActive

Key Facts

Indication
Inflammatory Bowel Disease
Phase
Discovery/Pre-clinical
Status
Active
Company
Scipher Medicine

About Scipher Medicine

Scipher Medicine is a private, commercial-stage diagnostics company focused on transforming the treatment of autoimmune diseases through precision medicine. Its core asset is the PrismRA blood test, a commercially launched molecular signature test to predict response to anti-TNF therapy in rheumatoid arthritis, which has secured Medicare coverage. The company's foundation is its Spectra AI platform, which analyzes a vast registry of real-world clinico-genomic data to discover biomarkers, guide therapeutic development, and provide commercialization insights, supported by partnerships with pharmaceutical companies like Galapagos and Ionis.

View full company profile

Therapeutic Areas

Rheumatoid ArthritisAutoimmune DiseasesInflammatory Bowel Disease

Other Inflammatory Bowel Disease Drugs

DrugCompanyPhase
DVI-001DivamicsPreclinical
DVI-002DivamicsPreclinical
Turq-101Turquoise BiotechnologiesPreclinical
GS-4875GileadPhase 2
Function-based Consortium for IBDPharmaBiomePre-clinical
IBD SubclassificationBio-MeResearch
Anti-iRhom2 antibodiesSciRhomPre-clinical
IBD Multi-omics DatasetOvation.ioCommercial
Noa‑001Noa TherapeuticsPreclinical
InflectraEMSPhase 3
IW-601ImmuneWalk TherapeuticsPreclinical
TRWR‑IBDTaiwan Resonant Waves ResearchPreclinical